Reply to B. Mutlu Sütcüoğlu et al

Gemma Kenter¹, Stefano Greggi¹, Ignace Vergote¹+2

• ¹Gemma Kenter, MD, PhD, Center Gynaecological Cancer Amsterdam, Amsterdam, the Netherlands; Stefano Greggi, MD, PhD, National Institute Cancer Napels, Naples, Italy; Ignace Vergote, MD, PhD, Katholieke universiteit Leuven, Leuven, Belgium; Corneel Coens, PhD, EORTC, Brussels, Belgium; and Antonio Casado, MD, PhD, University of Madrid, Madrid, Spain.